Successful percutaneous coronary intervention for acute coronary syndrome in a patient with severe hemophilia A

Korean Circulation Journal

Volumn 40, Issue 10, 2010, Pages 527-529

  Kim, Dong Kie ^a   Kim, Doo Il ^a   Kim, Mo Se ^a   Lee, Eun Ji ^a   Kim, Young Bok ^a   Cho, Hwan Jin ^b   Han, Yang Chun ^c   Kim, Ung ^a   Seol, Sang Hoon ^a   Yang, Tae Hyun ^a   Kim, Dae Kyung ^a   Kim, Dong Soo ^a  

^a Inje University College of Medicine   (South Korea)

^b Ulsan General Hospital   (South Korea)

^c Changwon Fatima Hospital   (South Korea)

Author keywords

Acute coronary syndrome; Hemophilia A; Percutaneous transluminal angioplasty

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BLOOD CLOTTING FACTOR 8; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; GREENMONO; HEPARIN; ISOSORBIDE DINITRATE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY BLOOD CLOTTING FACTOR 8; NICORANDIL; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CASE REPORT; CIGARETTE SMOKING; CORONARY STENT; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; HEART CATHETERIZATION; HEMOPHILIA A; HUMAN; LOADING DRUG DOSE; MALE; PERCUTANEOUS CORONARY INTERVENTION; PHYSICAL EXAMINATION; THORAX PAIN; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 78649416018     PISSN: 17385520     EISSN: 17385555     Source Type: Journal    
DOI: 10.4070/kcj.2010.40.10.527     Document Type: Article

References (13)

1. Plug I, van der Born JG, Peters M, et al. Mortality and causes of death in patients with hemophilia, 1992-2001: a prospective cohort study. J Thromb Haemost 2006;4:510-6.
2. Rosendaal FR, Briet E, Stibbe J, et al. Haemophilia protects against ischaemic heart disease: a study of risk factors. Br J Haematol 1990;75:525-30.
3. Srmek A, Kriek M, Rosendaal FR. Decreased mortality of ischaemic heart disease among carriers of haemophilia. Lancet 2003;362:351-4.
4. Srmek A, Reiber JH, Gerrits WB, Rosendaal FR. Decreased coagulability has no clinically relevant effect on atherogenesis: observations in individuals with a hereditary bleeding tendency. Circulation 2001;104:762-7.
5. Girolami A, Ruzzon E, Fabris F, Varvarikis C, Sartori R, Girolami B. Myocardial infarction and other arterial occlusions in hemophilia a patients. a cardiological evaluation of all 42 cases reported in the literature. Acta Haematol 2006;116:120-5.
6. Bond L, Bevan D. Myocardial infarction in a patient with hemophilia treated with DDAVP. N Engl J Med 1988;318:121.
7. Arora U, Dhir M, Cintron G, Strom JA. Successful multi-vessel percutaneous coronary intervention with bivalirudin in a patient with severe hemophilia A: a case report and review of literature. J Invasive Cardiol 2004;16:330-2.
8. Krolick MA. Successful percutaneous coronary intervention in a patient with severe haemophilia A using bivalirudin as the sole procedural anticoagulant. Haemophilia 2005;11:415-7.
9. Park DW, Park SW. Stent thrombosis in the era of the drug-eluting stent. Korean Circ J 2005;35:791-4.
10. Brener SJ, Steinhubl SR, Berger PB, Brennan DM, Topol EJ. Prolonged dual antiplatelet therapy after percutaneous coronary intervention reduces ischemic events without affecting the need for repeat revascularization: insights from the CREDO trial. J Invasive Cardiol 2007;19:287-90.
11. Bovenzi F, De Luca L, Signore N, Fusco F, de Luca I. Abciximab for the treatment of an acute thrombotic coronary occlusion during stent implantation in a patient with severe hemophilia B. Ital Heart J 2003;4:728-30.
12. MacKinlay N, Taper J, Renisson F, Rickard K. Cardiac surgery and catheterization in patients with haemophilia. Haemophilia 2000;6:84-8.
13. Ferrario C, Renders F, Cairoli A, Vuffray A, Spertini O, Angelillo-Scherrer A. Management of an acute coronary syndrome in a patient tvv with severe haemophilia A. Haemophilia 2007;13:763-5.